MicroRNA-20a-5p inhibits epithelial to mesenchymal transition and invasion of endometrial cancer cells by targeting STAT3.

BACKGROUND Endometrial cancer (EC) is the fourth most common malignancy among women. Epithelial to mesenchymal transition (EMT) and invasion have been identified as central cellular processes in tumor progression and malignant transformation. The function and molecular basis of microRNA-20a-5p (miR-20a-5p) in the development of EC are poorly defined. METHODS RT-qPCR assay was used to detect the levels of miR-20a-5p and signal transducer and activator of transcription 3 (STAT3) mRNA. Western blot assay was conducted to determine protein expression of STAT3, N-cadherin, Vimentin and E-cadherin. Cell invasive capacity was examined by transwell invasion assay. Bioinformatics analysis, luciferase reporter assay and RIP assay were performed to investigate the interaction between miR-20a-5p and STAT3 3'UTR. RESULTS miR-20a-5p expression was strikingly reduced in EC tissues and cells. Functional analysis revealed that miR-20a-5p overexpression inhibited EMT and invasion of EC cells. Further exploration showed that miR-20a-5p inhibited STAT3 expression by direct interaction. Moreover, the knockdown of STAT3 suppressed EMT and invasion of EC cells. Additionally, the depletion of STAT3 weakened miR-20a-5p downregulation-induced cell EMT and invasion in EC. CONCLUSION miR-20a-5p inhibited EMT and invasion of EC cells by targeting STAT3, highlighting the vital roles of miR-20a-5p and STAT3 in the metastasis and malignant transformation of EC.

[1]  W. Peng,et al.  STAT3 activation by IL-6 from adipose-derived stem cells promotes endometrial carcinoma proliferation and metastasis. , 2018, Biochemical and biophysical research communications.

[2]  Ming-jun Sun,et al.  LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR‐20a‐5p/HMGA2 axis in breast cancer , 2018, Cancer medicine.

[3]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[4]  S. Biffo,et al.  Role of microRNAs in translation regulation and cancer , 2017, World journal of biological chemistry.

[5]  P. Goodfellow,et al.  Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target , 2017, Oncogene.

[6]  M. Sherman,et al.  High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database , 2016, International journal of cancer.

[7]  K. Torres,et al.  Erratum to: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer , 2016, BMC Cancer.

[8]  T. Song,et al.  MicroRNA-20a-5p targets RUNX3 to regulate proliferation and migration of human hepatocellular cancer cells. , 2016, Oncology reports.

[9]  Xi Chen,et al.  MicroRNA-93 Promotes Epithelial–Mesenchymal Transition of Endometrial Carcinoma Cells , 2016, PloS one.

[10]  George A. Calin,et al.  microRNA Therapeutics in Cancer — An Emerging Concept , 2016, EBioMedicine.

[11]  H. Mackay,et al.  Endometrial cancer: Not your grandmother's cancer , 2016, Cancer.

[12]  M. Burchardt,et al.  The future therapy of endometrial cancer: microRNA’s functionality, capability, and putative clinical application , 2016, Archives of Gynecology and Obstetrics.

[13]  E. Darai,et al.  Endometrial cancer , 2016, The Lancet.

[14]  I. G. Reed,et al.  Regulation of epithelial–mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs , 2016, Clinical and Translational Oncology.

[15]  Meenakshi Singh,et al.  Endometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical Dilemmas. , 2016, American journal of clinical pathology.

[16]  E. Kimura,et al.  Insights into Regulation of the miR-17-92 Cluster of miRNAs in Cancer , 2015, Front. Med..

[17]  N. Nikitakis,et al.  STAT3 Signaling in Cancer , 2015 .

[18]  D. Levy,et al.  STAT3 regulated ARF expression suppresses prostate cancer metastasis , 2015, Nature Communications.

[19]  A. Zaravinos The Regulatory Role of MicroRNAs in EMT and Cancer , 2015, Journal of oncology.

[20]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[21]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[22]  S. Baka,et al.  The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review , 2015, Archives of Gynecology and Obstetrics.

[23]  M. Goel,et al.  Tumor progression, metastasis and modulators of EMT in endometrioid endometrial , 2015 .

[24]  Ming Zhou,et al.  MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1 , 2014, Cancer biology & therapy.

[25]  L. Pfeffer,et al.  Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer , 2014, Breast Cancer Research and Treatment.

[26]  R. Lai,et al.  STAT3 in Cancer—Friend or Foe? , 2014, Cancers.

[27]  Tong Li,et al.  miR‐20a Promotes Prostate Cancer Invasion and Migration Through Targeting ABL2 , 2014, Journal of cellular biochemistry.

[28]  P. Dong,et al.  MicroRNA‐106b modulates epithelial–mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines , 2014, Molecular carcinogenesis.

[29]  K. Hong,et al.  miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3 , 2013, Molecular and Cellular Biochemistry.

[30]  D. Aoki,et al.  MicroRNAs in endometrial cancer , 2013, International Journal of Clinical Oncology.

[31]  Shih-Chieh Lin,et al.  Hypoxia-induced microRNA-20a expression increases ERK phosphorylation and angiogenic gene expression in endometriotic stromal cells. , 2012, The Journal of clinical endocrinology and metabolism.

[32]  Jie Xiang,et al.  Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis , 2010, Current genomics.

[33]  R. Agami,et al.  Tumorigenicity of the miR-17-92 cluster distilled. , 2010, Genes & development.

[34]  J. Mendell miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.

[35]  J. Lin,et al.  Stat3 activation in human endometrial and cervical cancers , 2007, British Journal of Cancer.